LCerebellar Metastases From Prostate Cancer on 68Ga-PSMA PET/CT

被引：20
|
作者：
Chan, Mico [1 ]
Hsiao, Edward [1 ]
Turner, Jennifer [2 ,3 ]
机构：
[1] Royal North Shore Hosp, Dept Nucl Med, Reserve Rd, St Leonards, NSW 2065, Australia
[2] Douglass Hanly Moir Pathol, Dept Histopathol, Sydney, NSW, Australia
[3] Macquarie Univ, Fac Med & Hlth Sci, Sydney, NSW, Australia
来源：
CLINICAL NUCLEAR MEDICINE | 2017年 / 42卷 / 03期
关键词：
Ga-68-PSMA PET/CT; brain metastases; prostate cancer; BRAIN METASTASIS; CARCINOMA;
D O I：
10.1097/RLU.0000000000001526
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Ga-68 prostate-specific membrane antigen PET/CT is increasingly used to evaluate extent of disease in prostate carcinoma. Parenchymal brain metastases originating from prostate cancer have highly variable imaging appearance. We present a 77-year-old man with cerebellar metastasis from prostate cancer showing focal uptake on prostate-specific membrane antigen PET/CT.
引用
收藏
页码：193 / 194
页数：2
相关论文
共 50 条
  • [31] The Utility of 68Ga-PSMA PET/CT in Poorly Differentiated Metastatic Prostate Cancer
    Demirkol, Mehmet Onur
    Kiremit, Murat Can
    Acar, Omer
    Ucar, Burcu
    Saglican, Yesim
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (05) : 403 - 405
  • [32] Comparisons of mpMRI, 68Ga-PSMA PET/CT and mpMRI combined with 68Ga-PSMA PET/CT in diagnosing prostate cancer based on tumor detection, localization and staging
    Mai, Zhipeng
    Zhu, Ming
    Feng, Tianrui
    Zhou, Zhien
    Zhou, Yi
    Wang, Dong
    Yuan, Runqiang
    Xiao, Yu
    Wang, Jiarou
    Sun, Hao
    Yan, Weigang
    WORLD JOURNAL OF UROLOGY, 2024, 42 (01)
  • [33] 68Ga-PSMA PET/CT in prostate cancer patients - normal variants and pitfalls
    Keidar, Zohar
    Gill, Rona
    Goshen, Elinor
    Pirmisashvili, Natalia
    Israel, Ora
    Morgulis, Maryna
    Ben-Haim, Simona
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [34] Complimentary role of 68Ga-GRPR PET/CT and 68GA-PSMA PET/CT in initial diagnosis of prostate cancer
    Gao, X.
    Tang, Y.
    Chen, M.
    Li, J.
    Yin, H.
    Gan, Y.
    Zu, X.
    Cai, Y.
    Hu, S.
    HISTOPATHOLOGY, 2022, 81 : 134 - 134
  • [35] Imaging of Prostate Cancer Recurrence in the Vas Deferens With 68Ga-PSMA PET/CT
    Priftakis, Dimitrios
    Afaq, Asim
    Bomanji, Jamshed
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (01) : 49 - 51
  • [36] Comparison of 68Ga-PSMA PET/CT and MRI in evaluating the lateralization of prostate cancer
    Wang, M.
    Quan, Z.
    Zhao, X.
    Han, T.
    Meng, X.
    Kang, F.
    Wang, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S495 - S495
  • [37] Myelofibrosis Pattern in 68Ga-PSMA PET/CT of a Patient With Recurrence Prostate Cancer
    Kunikowska, Jolanta
    Pelka, Kacper
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (02) : E182 - E183
  • [38] Hybrid 68Ga-PSMA PET-CT for primary prostate cancer staging
    Lee, J.
    BJU INTERNATIONAL, 2017, 119 : 55 - 56
  • [39] Correlations of 68Ga-PSMA PET/CT in the initial staging of prostate cancer patients
    Topuz, Ozge Vural
    Aksu, Aysegul
    Erinc, Sadife Ruya
    Tamam, Muge Oner
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2021, 24 (01): : 60 - 65
  • [40] Immunohistochemical Validation of PSMA Expression Measured by 68Ga-PSMA PET/CT in Primary Prostate Cancer
    Woythal, Nadine
    Arsenic, Ruza
    Kempkensteffen, Carsten
    Miller, Kurt
    Janssen, Jan-Carlo
    Huang, Kai
    Makowski, Marcus R.
    Brenner, Winfried
    Prasad, Vikas
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (02) : 238 - 243
12345